Business
Wiley and OpenEvidence Partner to Deliver Trusted Research to Physicians at the Point of Care
HOBOKEN, N.J., March 03, 2026--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of clinical practice, scientific discovery and learning, and OpenEvidence, the most widely used medical AI platform in the world, today announced a strategic partnership to bring Wiley's trusted scientific and medical content into OpenEvidence. Through the partnership, physicians using OpenEvidence at the point of care can rely on content from hundreds of Wiley
About this update from John Wiley & Sons, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/a703c553d651575892d7a7a32c76c1f1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/boKWITANRmsF0nGN8P7OZQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/a703c553d651575892d7a7a32c76c1f1","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/9Z9vKj_lJllob2_bDOWb9Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/a703c553d651575892d7a7a32c76c1f1","width":1024,"height":512}},"lazy":false},{"type":"text","content":"A new content agreement deepens the medical literature physicians can retrieve, synthesize, and verify through AI-assisted clinical questions","length":141,"tagName":"p","attribs":{}},{"type":"text","content":"HOBOKEN, N.J., March 03, 2026--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of clinical practice, scientific discovery and learning, and OpenEvidence, the most widely used medical AI platform in the world, today announced a strategic partnership to bring Wiley's trusted scientific and medical content into OpenEvidence. Through the partnership, physicians using OpenEvidence at the point of care can rely on content from hundreds of Wiley’s peer-reviewed journals and resources across key medical specialties to support their clinical decisions.","length":628,"tagName":"p"},{"type":"text","content":"Medical knowledge doubles every 73 days. Historically, published research has taken an average of 17 years to reach clinical practice. Helping doctors make point-of-care decisions grounded in the best and latest science requires more than capable AI; it needs the right underlying content. OpenEvidence was built on a principle its founders call "gold in, gold out": specialized models trained on peer-reviewed literature, not the open internet, with every answer grounded in sources a physician can drill into and verify. By joining OpenEvidence’s existing network of content partners, Wiley extends that foundation.","length":627,"tagName":"p"},{"type":"text","content":""The hard problem in medicine right now isn’...